Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 299
Filter
1.
Int Endod J ; 53(6): 804-811, 2020 Jun.
Article in English | MEDLINE | ID: mdl-32011747

ABSTRACT

AIM: To examine DNA methylation of GJA1, BMP2 and BMP4 in human cementoblasts (HCEM) induced by lipopolysaccharide (LPS). METHODOLOGY: HCEM were cultured in osteoinduction medium. After 24 h, Escherichia coli LPS (1 µg/mL) was added to the medium, which was changed every 2-3 days. Untreated samples were used as controls. Messenger RNA was extracted after 4 weeks, and quantitative real-time polymerase chain reaction (qRT-PCR) for GJA1, BMP2, BMP4 and DNMT1 was performed. Genomic DNA was extracted after 4 weeks, and quantitative methylation-specific polymerase chain reaction was carried out for GJA1, BMP2 and BMP4. To detect mineralization, alizarin red and alkaline phosphatase staining were performed. The cells were also treated with the DNA methyltransferase inhibitor 5-Aza-2'-deoxycytidine (5Aza) and examined. The significance of differences amongst groups was assessed using a two-way analysis of variance (ANOVA) followed by Bonferroni's multiple comparison test with P < 0.05 being significant. RESULTS: Decreased expression of mRNA was seen in GJA1, BMP2 and BMP4 after 4 weeks (P < 0.05). DNA hypermethylation was detected in GJA1, BMP2 and BMP4 (P < 0.05). Alizarin red staining and alkaline phosphatase staining revealed decreased mineralization levels in HCEM stimulated with LPS. 5Aza abolished the effects of DNA methylation in HCEM stimulated with LPS. CONCLUSIONS: These results suggest that long-term LPS stimulation induces DNA methylation of GJA1, BMP2 and BMP4 in HCEM.


Subject(s)
DNA Methylation , Dental Cementum , Bone Morphogenetic Protein 2 , Bone Morphogenetic Protein 4 , Cell Differentiation , Cell Line , Cells, Cultured , Connexin 43 , Humans , Lipopolysaccharides
2.
Oral Dis ; 24(4): 518-526, 2018 May.
Article in English | MEDLINE | ID: mdl-28513096

ABSTRACT

Pathobiology of dental caries is complex. Data from recent molecular microbiologic studies have further redefined the role of the oral microbiome in the etiology of dental caries. This new information challenges the conventional view on the hegemony of classic cariogenic prokaryotes such as Streptococcus mutans in caries etiology, and raises the intriguing possibility of the participation of the eukaryotic oral fungal pathogen Candida in the caries process. The virulence attributes of Candida species such as their acidogenicity and aciduric nature, the ability to develop profuse biofilms, ferment and assimilate dietary sugars, and produce collagenolytic proteinases are all indicative of their latent cariogenic potential. Based on the above, oral candidal counts have been used by some as a caries risk indicator. On the contrary, other studies suggest that Candida is merely a passenger extant in an acidic cariogenic milieu, and not a true pathogen. In this review, we critically examine the varying roles of Candida, and traditionally accepted cariogens such as the mutans group of streptococci in the pathobiology of dental caries. The weight of available data tends to imply that Candida may play a pivotal role as a secondary agent perpetuating the carious process, especially in dentinal caries.


Subject(s)
Biofilms , Candida albicans/metabolism , Carbohydrate Metabolism , Dental Caries/microbiology , Streptococcus mutans/metabolism , Acids/metabolism , Candida albicans/enzymology , Humans
3.
Diabetes Obes Metab ; 17(4): 430-4, 2015 Apr.
Article in English | MEDLINE | ID: mdl-25146418

ABSTRACT

This study was initiated to evaluate the association of acute pancreatitis (AP) with the use of dipeptidyl peptidase-4 (DPP-4) inhibitors among patients with diabetes in Japan. A retrospective cohort study of a large medical and pharmacy claims database was performed to compare the incidence of AP among those receiving DPP-4 inhibitors and those receiving other oral antidiabetic drugs. The incidence of all AP and hospitalizations for AP was similar between the two groups. Previous exposure to DPP-4 inhibitors did not affect occurrence of AP in patients on other oral antidiabetic drugs. The Kaplan-Meier curve for time to AP was similar between the two groups, and was not affected by previous exposure to DPP-4 inhibitors. The Cox proportional hazard models showed the incidence of AP was not significantly higher in those receiving DPP-4 inhibitors. Despite numerous, important limitations related to claims database-based analyses, our results indicate that there is no increased risk of AP with use of DPP-4 inhibitors among patients with diabetes in Japan.


Subject(s)
Diabetes Mellitus, Type 2/drug therapy , Dipeptidyl-Peptidase IV Inhibitors/adverse effects , Hypoglycemic Agents/adverse effects , Pancreas/drug effects , Pancreatitis/chemically induced , Administration, Oral , Adult , Aged , Cohort Studies , Databases, Factual , Diabetes Mellitus, Type 2/immunology , Dipeptidyl-Peptidase IV Inhibitors/administration & dosage , Dipeptidyl-Peptidase IV Inhibitors/therapeutic use , Female , Health Benefit Plans, Employee , Hospitalization , Humans , Hypoglycemic Agents/administration & dosage , Hypoglycemic Agents/therapeutic use , Incidence , Japan/epidemiology , Male , Middle Aged , Pancreas/immunology , Pancreatitis/epidemiology , Pancreatitis/immunology , Pancreatitis/therapy , Retrospective Studies , Risk , Survival Analysis
4.
Caries Res ; 48(5): 353-60, 2014.
Article in English | MEDLINE | ID: mdl-24603299

ABSTRACT

This study proposes a bioprospection methodology regarding the antimicrobial potential of plant extracts against bacteria with cariogenic relevance. Sixty extracts were obtained from ten plants--(1) Jatropha weddelliana, (2) Attalea phalerata, (3) Buchenavia tomentosa, (4) Croton doctoris, (5) Mouriri elliptica, (6) Mascagnia benthamiana, (7) Senna aculeata, (8) Unonopsis guatterioides, (9) Allagoptera leucocalyx and (10) Bactris glaucescens--using different extraction methods - (A) 70° ethanol 72 h/25°C, (B) water 5 min/100°C, (C) water 1 h/55°C, (D) water 72 h/25°C, (E) hexane 72 h/25°C and (F) 90° ethanol 72 h/25°C. The plants were screened for antibacterial activity at 50 mg/ml using the agar well diffusion test against Actinomyces naeslundii ATCC 19039, Lactobacillus acidophilus ATCC 4356, Streptococcus gordonii ATCC 10558, Streptococcus mutans ATCC 35688, Streptococcus sanguinis ATCC 10556, Streptococcus sobrinus ATCC 33478 and Streptococcus mitis ATCC 9811. The active extracts were tested to determine their minimum inhibitory concentration (MIC), minimum bactericidal concentration (MBC), cytotoxicity and chemical characterization. Forty-seven extracts (78%) were active against at least one microorganism. Extract 4A demonstrated the lowest MIC and MBC for all microorganisms except S. gordonii and the extract at MIC concentration was non-cytotoxic. The concentrated extracts were slightly cytotoxic. Electrospray ionization with tandem mass spectrometry analyses demonstrated that the extract constituents coincided with the mass of the terpenoids and phenolics. Overall, the best results were obtained for extraction methods A, B and C. The present work proved the antimicrobial activity of several plants. Particularly, extracts from C. doctoris were the most active against bacteria involved in dental caries disease.


Subject(s)
Anti-Bacterial Agents/pharmacology , Dental Caries/microbiology , Gram-Positive Bacteria/drug effects , Phytotherapy/methods , Plant Extracts/pharmacology , Actinomyces/drug effects , Annonaceae/chemistry , Arecaceae/chemistry , Brazil , Combretaceae/chemistry , Croton/chemistry , Humans , Jatropha/chemistry , Lactobacillus acidophilus/drug effects , Malpighiaceae/chemistry , Melastomataceae/chemistry , Microbial Sensitivity Tests , Phenols/analysis , Plant Extracts/chemistry , Senna Extract/chemistry , Solvents/chemistry , Streptococcus gordonii/drug effects , Streptococcus mitis/drug effects , Streptococcus mutans/drug effects , Streptococcus sanguis/drug effects , Streptococcus sobrinus/drug effects , Temperature , Terpenes/analysis
5.
J Oral Pathol Med ; 42(7): 570-5, 2013 Aug.
Article in English | MEDLINE | ID: mdl-23278631

ABSTRACT

BACKGROUND: The aim of this study was to evaluate the frequency of Candida species and presence of lesions in the oral cavity of patients with sickle cell anemia (SS). METHODS: The study included 30 patients diagnosed with sickle cell anemia and taking hydroxyurea for at least 90 days (SS/HU+); and 39 patients with sickle cell anemia and without hydroxyurea therapy (SS/HU-). Two control groups were constituted by healthy individuals matched to the test groups in age, gender, and oral conditions (C/HU+ for SS/HU+ and C/HU- for SS/HU-). Oral clinical examination and anamnesis were performed. Yeasts were collected by oral rinses and identified by API system. Antifungal susceptibility evaluation was performed according to the CLSI methodology. Data obtained for microorganisms counts were compared by Student's t test (SS/HU+ vs. C/HU+ and SS/HU- vs. C/HU-) using MINITAB for Windows 1.4. Significance level was set at 5%. RESULTS: No oral candidosis lesions were detected. Significant differences in yeasts counts were observed between SS/HU- group and the respective control, but there were no differences between SS/HU+ and C/HU+. Candida albicans was the most prevalent species in all groups. Candida famata was observed both in SS and control groups. Candida dubliniensis, Candida glabrata, Candida krusei, Candida tropicalis, Candida pelliculosa, and Candida parapsilosis were observed only in SS groups. Most strains were susceptible to all antifungal agents. CONCLUSION: Hydroxyurea therapy seems to decrease candidal counts and resistance rate in sickle cell anemia patients. However, further studies should be conducted in the future to confirm this finding. Hydroxyurea therapy in sickle cell anemia patients maintains fungal species balance in oral cavity.


Subject(s)
Anemia, Sickle Cell/drug therapy , Antifungal Agents/therapeutic use , Antisickling Agents/therapeutic use , Candidiasis, Oral/prevention & control , Hydroxyurea/therapeutic use , Adolescent , Adult , Candida/classification , Candida/drug effects , Candida glabrata/drug effects , Candida glabrata/isolation & purification , Candida tropicalis/drug effects , Candida tropicalis/isolation & purification , Case-Control Studies , Colony Count, Microbial , Cross-Sectional Studies , DMF Index , Drug Resistance, Fungal , Female , Fluconazole/pharmacology , Flucytosine/pharmacology , Humans , Ketoconazole/pharmacology , Male , Microbial Sensitivity Tests , Middle Aged , Mouth/microbiology , Saliva/metabolism , Secretory Rate/physiology , Young Adult
6.
Andrologia ; 45(6): 402-8, 2013 Dec.
Article in English | MEDLINE | ID: mdl-23113831

ABSTRACT

Unique membranous structures of intracytoplasmic organelle, sting of a stack of a few flat cisternae about 50 nm in thickness, were found in mouse and rat spermatocytes after micro-injection of immunoglobulin G into the lumina of the seminiferous tubules. Other proteins such as BSA and cytochrome c used in this study also induced the structures. In most cases, the stacks of cisternae were rolled up like cigars or cylinders. The structures varied in length and diameter, the largest one observed in this study being 10.7 µm in length. The structures did not appear when the testes were fixed just after micro-injection and were formed transiently: they were observed in the spermatocytes fixed between 1 and 4 h after injection. Cytochrome c, micro-injected as an inter-cellular tracer, was visualised by a diaminobenzidine reaction. As the reaction product was not contained in the cisternae of the unique structures, the lumen of the cisternae of the organelles was not continuous with the inter-cellular space. A flocculent material of low density was observed in the cisternae of the organelle. Similar material was observed in the lumina of solitary cisternae of the rough endoplasmic reticulum in the spermatocytes, suggesting that the structures derived from endoplasmic reticulum.


Subject(s)
Organelles/ultrastructure , Spermatocytes/ultrastructure , Animals , Male , Mice , Rats
7.
Gene Ther ; 19(5): 476-82, 2012 May.
Article in English | MEDLINE | ID: mdl-22113310

ABSTRACT

Varying degrees of metabolic abnormalities mediated by chronic inflammation are implicated in the chronic glomerular injuries associated with obesity. Interleukin (IL)-10, a pleiotropic cytokine, exerts anti-inflammatory effects in numerous biological settings. In the present study, we explored the biological benefits of adeno-associated virus (AAV) vector-mediated sustained IL-10 expression against the pathological renal characteristics observed in Zucker fatty rats (ZFRs). We injected an AAV vector, encoding rat IL-10 or enhanced green fluorescent protein (GFP) into male ZFRs at 5 weeks of age. Subsequently, the renal pathophysiological changes were analyzed. Persistent IL-10 expression significantly reduced the urinary protein excretion of ZFRs compared with GFP expression (47.1±11.6 mg per mg·creatinine versus 88.8±30.0 mg per mg·creatinine, P<0.01). The serum levels of IL-10 negatively correlated with the urinary protein in AAV-treated rats (r=-0.78, P<0.01). Renal hypertrophy, increased widths in the glomerular basement membrane, and the lack of uniformity and regularity of the foot process of the visceral glomerular epithelial cells of ZFRs were significantly blunted by IL-10 expression. IL-10 also abrogated the downregulation of glomerular nephrin observed in ZFRs treated with the GFP vector. Our findings provide insights into the potential benefit of the anti-inflammatory effects of IL-10 on the overall management of glomerulopathy induced by the metabolic disorders associated with obesity.


Subject(s)
Interleukin-10/genetics , Proteinuria/therapy , Animals , Dependovirus/genetics , Genetic Vectors , Interleukin-10/blood , Kidney/pathology , Kidney Glomerulus/metabolism , Male , Membrane Proteins/metabolism , Obesity/complications , Obesity/genetics , Proteinuria/genetics , Proteinuria/metabolism , Proteinuria/pathology , Rats , Rats, Zucker
8.
Lupus ; 21(9): 969-77, 2012 Aug.
Article in English | MEDLINE | ID: mdl-22453994

ABSTRACT

Treating patients with systemic lupus erythematosus (SLE) with steroids and immunosuppressive drugs may interfere in the presence of potentially opportunistic microorganisms in the oral cavity. The aim of this study was to evaluate the presence of Candida spp., Staphylococcus spp., Enterobacteria and Pseudomonas spp. in the oral cavity of SLE patients, compared with healthy controls. A group of 40 patients who had received therapy for at least 60 days was selected (19-53 years). For the control group, 40 healthy individuals matched for age, gender and use of partial prosthesis were selected. Oral rinse samples were collected and plated on specific culture media. After incubation, the number of colony forming units (CFU) was obtained and the isolates were identified at species level. Microbial counts were compared between SLE and control by analysis of variance (ANOVA) and Mann-Whitney (p < 0.05 significant). Microorganism counts in patients with and without immunosuppressive drugs, as well with active and inactive disease (according to SLEDAI score) were also compared. No significant differences in CFU/mL between SLE and control patients were observed (yeasts, p = 0.55; Staphylococci, p = 0.24; Enterobacteria/Pseudomonas spp., p = 0.26). No differences in microbial counts were observed regarding clinical parameters tested. The most frequent species isolated in the SLE group were Candida albicans, Staphylococcus epidermidis and Klebsiella oxytoca. In conclusion, no differences in frequency and microorganism levels were found between SLE patients and healthy individuals.


Subject(s)
Bacteria/isolation & purification , Lupus Erythematosus, Systemic/microbiology , Mouth/microbiology , Adult , Candida/isolation & purification , Enterobacter/isolation & purification , Female , Humans , Lupus Erythematosus, Systemic/drug therapy , Middle Aged , Staphylococcus/isolation & purification
9.
Andrologia ; 43(3): 180-8, 2011 Jun.
Article in English | MEDLINE | ID: mdl-21486398

ABSTRACT

RA175, a member of the immunoglobulin superfamily, plays an important role in cell adhesion, and RA175 gene-deficient mice (RA175(-/-) ) show oligoastheno-teratozoospermia. To understand the function of RA175, location in the testis and the morphological features of its spermatogenic cells in RA175(-/-) mice were investigated. Immunohistochemical studies revealed that RA175 immunoreactivity was observed on the cell surface of the spermatogenic cells at specific stages. A strong reaction was detected from type A spermatogonia to pachytene spermatocytes at stage IV and from step 6 to step 16 spermatids during spermatogenesis. From pachytene spermatocytes at stage VI to step 4 spermatids, the reaction was not detected by the enzyme-labelled antibody method and was faintly detected by the indirect immunofluorescence method. Abnormal vacuoles in the seminiferous epithelium, showing exfoliation of germ cells, and ultrastructural abnormality of the elongate spermatids were revealed in the RA175(-/-) testes. Other members of the immunoglobulin superfamily such as basigin, nectin-2 and nectin-3, which have an important role in spermatogenesis, were immunohistochemically detected in the RA175(-/-) testis. These observations indicate a unique expression pattern of RA175 in the testis and provide clues regarding the mechanism of male infertility in the testis.


Subject(s)
Cell Adhesion Molecules/metabolism , Immunoglobulins/metabolism , Testis/metabolism , Animals , Basigin/metabolism , Cell Adhesion Molecule-1 , Cell Adhesion Molecules/deficiency , Immunoglobulins/deficiency , Immunohistochemistry , Infertility, Male , Male , Mice , Nectins , Spermatogenesis/physiology , Testis/ultrastructure
10.
J Exp Med ; 175(3): 647-54, 1992 Mar 01.
Article in English | MEDLINE | ID: mdl-1740659

ABSTRACT

Immunological and biochemical characteristics of the Qa-2 murine nonclassical histocompatibility class 1 antigen expressed on tumor cells derived from H-2k (Qa-2-) mice were studied. It was found that the Qa-2 antigen on normal H-2b lymphocytes reacted with Qa-2-specific monoclonal antibodies (mAbs) 34-1.2, 59 (both specific to the alpha 1/alpha 2 region) and 141-15.8 (specific to the alpha 3 domain), and the Qa-2 antigen on H-2k tumor cells (Qa-2k antigen) reacted with mAbs 59 and 141-15.8, but not with 34-1.2. The normal Qa-2 antigen was susceptible to treatment with phosphatidylinositol-specific phospholipase C, but the Qa-2k antigen was insensitive to it. By Northern hybridization, polymerase chain reaction (PCR) studies on cDNA, Southern hybridization, Western blotting, and nucleotide sequence analysis, the Q5k gene was identified as the gene encoding the Qa-2k antigen expressed on BW5147 lymphoma cells derived from a mouse of AKR strain (H-2k, Qa-2-). The nucleotide sequence of PCR-amplified BW5147 Q5k cDNA showed complete agreement with the reported sequence of exons 1-5 of the Q5k gene of C3H/He. It also showed complete deletion of the region corresponding to exons 6 and 7, and a very short coding region in exon 8, resulting in very short cytoplasmic domain of the product compared with regular class 1 antigens. These characteristics were expected from the reported Q5k genomic sequence. These results revealed that the Qa-2k antigen was distinct from the normal Qa-2 antigen expressed on H-2b lymphocytes although it cross-reacted with some Qa-2-specific mAbs.


Subject(s)
Histocompatibility Antigens Class I/genetics , Amino Acid Sequence , Animals , Base Sequence , H-2 Antigens/analysis , Immunoblotting , Mice , Mice, Inbred AKR , Mice, Inbred C3H , Molecular Sequence Data , Phenotype , Tumor Cells, Cultured/immunology
11.
Minerva Stomatol ; 59(7-8): 415-21, 2010.
Article in English | MEDLINE | ID: mdl-20842079

ABSTRACT

AIM: The aim of this paper was to evaluate the antimicrobial activity of 2% chlorhexidine gel (CLX) associated with various intracanal medicaments against Candida albicans and Enterococcus faecalis inoculated in root canals. METHODS: Thirty six human single-rooted teeth were contaminated with C.albicans and E.faecalis. The canals were instrumented using 2% CLX gel and were divided into three groups according to the intracanal medicaments (ICM) used. Group 1: calcium hydroxide paste [Ca(OH)2], Group 2: 2% chlorhexidine gel (CLX) and Group 3: 2% CLX gel + Ca(OH)2. The root canal collections were performed after 21 days of contamination (control collection), after instrumentation (1st collection), after 14 days of intracanal medicament (2nd collection) and 7 days after medicament removal (3rd collection). The microbiological samples were plated in culture media and incubated for 48 hours. The results were submitted to Kruskal-Wallis test (P ≤ 0.05). RESULTS: It was verified that the instrumentation with CLX reduced the number of CFU/ml significantly when compared with the confirmation collection (control). However, the use of the ICM was only capable to eliminate completely the microorganisms in the root canals without difference statistics between them. CONCLUSION: Although the use of 2% chlorherixidine gel reduces the number of microorganisms significantly, only the ICM calcium hydroxide and calcium hydroxide associated with chlorhexidine are able to eliminate these microorganisms completely.


Subject(s)
Candida albicans/drug effects , Chlorhexidine/analogs & derivatives , Dental Pulp Cavity/microbiology , Enterococcus faecalis/drug effects , Bacterial Load , Calcium Hydroxide/pharmacology , Candida albicans/growth & development , Candida albicans/isolation & purification , Chlorhexidine/pharmacology , Dental Instruments , Drug Synergism , Enterococcus faecalis/growth & development , Enterococcus faecalis/isolation & purification , Equipment Contamination , Gels , Humans , In Vitro Techniques , Microbial Sensitivity Tests
12.
Leuk Res ; 86: 106222, 2019 11.
Article in English | MEDLINE | ID: mdl-31522038

ABSTRACT

INTRODUCTION: Mouse double minute 2 protein (MDM2), a negative regulator of the p53 tumour suppressor gene, is frequently amplified in malignancies. MDM2 antagonists have shown efficacy in treating malignancies with MDM2 overexpression and can overcome chemoresistance in acute myeloid leukemia. We systematically evaluated the safety profile of MDM2 inhibitors in the treatment of solid organ and hematologic malignancies. MATERIALS AND METHODS: We searched Medline and EMBASE from January 1947 to November 2018 for prospective clinical studies, in English or French, investigating any MDM2 inhibitor in pediatric or adult cancers, and reporting dose and toxicity outcomes. Primary outcome was dose-limiting toxicity (DLT) and secondary outcome was death. RESULTS: The search yielded 493 non-duplicate citations. Eighteen studies of 10 inhibitors met inclusion criteria (total N = 1005 patients). Two-thirds of included studies did not define DLTs and the reporting of toxicities was highly variable. The most commonly reported DLTs were cytopenias, gastrointestinal toxicity, metabolic disturbances, fatigue and cardiovascular toxicity; there was one death attributed to treatment toxicity. CONCLUSION: MDM2 antagonists have been studied in a variety of malignancies with toxicities similar to other commonly used chemotherapy agents and may represent a safe adjuvant treatment for further study in in acute leukemia.


Subject(s)
Antineoplastic Agents/adverse effects , Drug-Related Side Effects and Adverse Reactions/diagnosis , Hematologic Neoplasms/drug therapy , Proto-Oncogene Proteins c-mdm2/antagonists & inhibitors , Drug-Related Side Effects and Adverse Reactions/etiology , Evaluation Studies as Topic , Hematologic Neoplasms/pathology , Humans , Maximum Tolerated Dose , Prognosis
13.
Mater Sci Eng C Mater Biol Appl ; 98: 800-807, 2019 May.
Article in English | MEDLINE | ID: mdl-30813086

ABSTRACT

In the present study, we report the preparation of antifungal and non-cytotoxic polymer nanocomposites with potential application in biomedical materials. Dodecanethiol-protected silver nanoparticles (AgNPs-DDT) were synthesized by a reduction/precipitation method and dispersed in chloroform to obtain stable colloidal dispersions. PBAT-based nanocomposites containing 0.25, 0.5 and 2 wt% AgNPs-DDT were prepared by casting method. The incorporation of AgNPs-DDT in PBAT matrix resulted in nanocomposites which combine improved mechanical performance and antifungal properties with a non-cytotoxic characteristic.


Subject(s)
Antifungal Agents/pharmacology , Metal Nanoparticles/chemistry , Nanocomposites/chemistry , Polyesters/chemistry , Silver/chemistry , Sulfhydryl Compounds/chemistry , Calorimetry, Differential Scanning , Candida albicans/drug effects , Cell Death/drug effects , Cell Line , Elasticity , Humans , Microbial Sensitivity Tests , Nanocomposites/ultrastructure , Particle Size , Rheology , Viscosity
14.
Bone Marrow Transplant ; 42(3): 197-9, 2008 Aug.
Article in English | MEDLINE | ID: mdl-18500372

ABSTRACT

This study aimed to retrospectively evaluate the incidence of kerato-conjunctivitis in patients receiving TBI followed by high-dose cytarabine, and to clarify how effectively topical corticosteroid eye drops prevent kerato-conjunctivitis in these patients. Fifty-three patients who received cytarabine at a dose of 3 g/m2 every 12 h for 4 days after receiving TBI (12 Gy) as a conditioning for allogeneic hematopoietic stem cell transplantation (HSCT) were evaluated. For the prophylaxis of kerato-conjunctivitis, all patients received betamethasone sodium phosphate eye drops every 6 h, starting 1 day before the first dose of cytarabine and continuing until 1 day after the last dose of cytarabine or the complete resolution of ocular symptoms. For grading of kerato-conjuncitivitis, the National Cancer Institute-Common Toxicity Criteria were used. Among the 53 patients, the grades of kerato-conjunctivitis were grade 0 in 13 patients, grade 1 in 6 patients (11.3%), grade 2 in 10 patients (18.9%) and grade 3 in 25 patients (47.2%). These results strongly suggest that topical corticosteroid eye drops could not effectively prevent the development of cytarabine-induced kerato-conjunctivitis in HSCT recipients who receive high-dose cytarabine following TBI. Further investigation into a more effective prophylaxis for cytarabine-induced kerato-conjunctivitis in this setting is required.


Subject(s)
Adrenal Cortex Hormones/therapeutic use , Cytarabine/adverse effects , Hematopoietic Stem Cell Transplantation/methods , Keratoconjunctivitis/chemically induced , Adolescent , Adult , Female , Humans , Keratoconjunctivitis/etiology , Leukemia/complications , Male , Middle Aged , Myelodysplastic Syndromes/complications , Transplantation Conditioning/adverse effects , Transplantation Conditioning/methods , Transplantation, Homologous , Whole-Body Irradiation
15.
Methods Find Exp Clin Pharmacol ; 29(6): 389-94, 2007.
Article in English | MEDLINE | ID: mdl-17922066

ABSTRACT

Several experimental chronic renal failure (CRF) models are available for testing new drugs. A CRF model induced by the intravenous injection of 2 mg/kg of doxorubicin (DXR) twice during a 20-day interval reportedly results in pathological characteristics similar to glomerular sclerosis seen clinically. However, it normally takes more than 16 weeks to create this CRF model. We used three methods of direct drug injection into the kidney of rats to determine the method that would induce CRF within 4 weeks; Method A: DXR was injected directly into both kidneys; Method B: DXR was injected directly into the left kidney immediately after right nephrectomy; Method C: DXR was injected directly into the left kidney 1 week before right nephrectomy, and DXR was injected again directly into the left kidney. As a result, urinary protein, blood urea nitrogen (BUN), creatinine and creatinine clearance were significantly changed >1 week after the injection of DXR by Method C. Quantification of tissue transforming growth factor-beta1 (TGF-beta1), which is a prime fibrogenic cytokine in renal fibrosis, significantly increased in the kidney. A light microscopic image showed glomerular decrement, tubular dilation and atrophy and vacuolation of parenchyma. In conclusion, the results of this study demonstrate that the DXR model using Method C develops CRF within 4 weeks.


Subject(s)
Disease Models, Animal , Doxorubicin/administration & dosage , Kidney Failure, Chronic , Kidney , Analysis of Variance , Animals , Creatinine/metabolism , Creatinine/urine , Fibrosis , Injections , Kidney/pathology , Kidney Failure, Chronic/chemically induced , Kidney Failure, Chronic/pathology , Male , Nephrectomy , Proteinuria/chemically induced , Rats , Rats, Wistar , Transforming Growth Factor beta1/blood
16.
Diabetes Metab ; 43(3): 261-264, 2017 Jun.
Article in English | MEDLINE | ID: mdl-27712966

ABSTRACT

AIMS: To examine the impact of glucose tolerance status on the development of coronary artery disease (CAD) in working-age men in Japan. METHODS: This population-based retrospective cohort study included 111,621 men aged 31-60 years [63,558 with normal glucose tolerance (NGT); 37,126 with prediabetes; 10,937 with diabetes]. The Cox proportional-hazards regression model was used to identify variables related to the incidence of CAD. RESULTS: Multivariate analysis showed that, compared with NGT, diabetes increased the risk of CAD by 17.3 times (95% CI: 6.36-47.0) at ages 31-40 years, by 2.74 times (95% CI: 1.85-4.05) at ages 41-50 years and by 2.47 times (95% CI: 1.69-3.59) at ages 51-60 years. The HRs for CAD in men with diabetes aged 31-40 equaled that of men with NGT aged 51-60 [18.2 (7.15-46.4) and 19.4 (8.28-45.4), respectively]. CONCLUSION: The impact of diabetes on CAD was markedly greater in men aged 31-40 years compared with those aged 41-60 years.


Subject(s)
Coronary Artery Disease/complications , Coronary Artery Disease/epidemiology , Glucose Intolerance/complications , Glucose Intolerance/epidemiology , Adult , Blood Glucose , Diabetes Mellitus, Type 2 , Glucose Tolerance Test , Humans , Japan/epidemiology , Male , Middle Aged , Prediabetic State , Retrospective Studies
17.
J Clin Oncol ; 14(8): 2370-6, 1996 Aug.
Article in English | MEDLINE | ID: mdl-8708730

ABSTRACT

PURPOSE: The relative cytotoxicity of prednisolone and dexamethasone in acute lymphoblastic leukemia (ALL) is controversial. We therefore compared the direct antileukemic activities of these compounds in stroma-supported cultures of leukemic lymphoblasts. MATERIALS AND METHODS: Bone marrow samples from children with B-lineage ALL were cultured on allogeneic bone marrow-derived stromal layers and exposed to various concentrations of glucocorticoids. After 4 days of culture, the number of viable leukemic cells was counted by flow cytometry and compared with that in parallel cultures without drugs. RESULTS: In 28 B-lineage ALL samples tested, the concentration producing 50% cytotoxicity (LC50) of prednisolone ranged from 2.0 to 7,978 nmol/L (median, 43.5 nmol/L), and that of dexamethasone from 0.6 to 327 nmol/L (median, 7.5 nmol/L). Despite the wide variability of responses among samples, there was an excellent correlation between LC50 values obtained with the two drugs (linear r = .99, P < .0001; Spearman rank-order r = .77, P < .0001). The median ratio of dexamethasone to prednisolone LC50 and LC90 values was 1:5.5 (range, 1:1.0 to 1:24.4 for LC50; 1:1.1 to 1:25.5 for LC90). Studies with ALL cell lines demonstrated that both drugs were cytotoxic through induction of apoptosis. Stromal layers did not absorb or inactivate measurable amounts of corticosteroids, which indicates that the assay system did not bias results toward increased drug resistance. CONCLUSION: In a bone marrow-derived microenvironment, dexamethasone is five to six times more cytotoxic (on a molar basis) than prednisolone, in agreement with the antiinflammatory activities of these drugs. This finding may serve to guide the selection of dexamethasone dosage in the treatment of ALL.


Subject(s)
Antineoplastic Agents, Hormonal/pharmacology , Burkitt Lymphoma/pathology , Dexamethasone/pharmacology , Glucocorticoids/pharmacology , Precursor Cell Lymphoblastic Leukemia-Lymphoma/pathology , Prednisolone/pharmacology , Adolescent , Apoptosis/drug effects , Bone Marrow Cells , Child , Child, Preschool , Flow Cytometry , Humans , Infant , Stromal Cells/cytology , Tumor Cells, Cultured/drug effects , Tumor Cells, Cultured/pathology
18.
Diabetes ; 32(4): 343-51, 1983 Apr.
Article in English | MEDLINE | ID: mdl-6832489

ABSTRACT

Comparison of the 75-g oral glucose tolerance test (OGTT) method was made with the conventional 50-g method in a fixed population followed for 1--17 yr. The possibility of using the results in establishing the diagnosis of diabetes mellitus was also considered. The following results were obtained: (1) The 75-g method showed significantly higher 2-h and 3-h postchallenge plasma glucose (PG) and immunoreactive insulin values. (2) The two methods showed good correlation in PG values at various time periods, and there was no difference between the two at 1/2 h and 1 h. The 2-h standard value of 200 mg/dl used to diagnose diabetes with the 75-g method was equivalent to 180 mg/dl by the 50-g method. The upper limits of normals were 140 mg/dl and 120 mg/dl, respectively, for the two tests. (3) Those subjects diagnosed as diabetic on the basis of fasting plasma glucose (FPG) values of 140--149 mg/dl only had a high rate of reverting to normal over time. The frequency of "nondiabetic" plasma glucose values after glucose loading steadily decreases as FPG increased, with separation into two asymptotic lines at 150 mg/dl level. Thus, the logical value for diagnosis of diabetes when based only on FPG value is considered to be 150 mg/dl. (4) A smaller number of individuals had 2-h PG values that satisfied criteria for diagnosis of diabetes mellitus, but 1/2-h and 1-h values that were less than 200 mg/dl. Nevertheless, follow-up of these subjects showed a high development rate of diabetes. Thus, the 1/2-h and 1-h values are not considered necessary to establish diagnosis of diabetes mellitus.


Subject(s)
Blood Glucose/analysis , Diabetes Mellitus/diagnosis , Glucose Tolerance Test/methods , Adult , Aged , Fasting , Follow-Up Studies , Humans , Middle Aged , Time Factors
19.
Leukemia ; 16(7): 1344-52, 2002 Jul.
Article in English | MEDLINE | ID: mdl-12094259

ABSTRACT

Clotrimazole is an antimycotic imidazole derivative that interferes with cellular Ca(2+) homeostasis. We investigated the effects of clotrimazole on acute lymphoblastic leukemia (ALL) cells. Treatment with 10 microM clotrimazole (a concentration achievable in vivo) reduced cell recovery from cultures of all nine ALL cell lines studied (B-lineage: OP-1, SUP-B15, RS4;11, NALM6, REH, and 380; T-lineage: MOLT4, CCRF-CEM, and CEM-C7). After 4 days of culture, median cell recovery was 10% (range, <1% to 37%) of cell recovery in parallel untreated cultures. Clotrimazole also inhibited recovery of primary ALL cells cultured on stromal feeder layers. After leukemic cells from 16 cases of ALL were cultured for 7 days with 10 microM clotrimazole, median cell recovery was <1% (range, <1% to 16%) of that in parallel untreated cultures. Clotrimazole was active against leukemic cells with genetic abnormalities associated with poor response to therapy and against multidrug-resistant cell lines. In contrast, mature T lymphocytes and bone marrow stromal cells were not affected. Clotrimazole induced depletion of intracellular Ca(2+) stores in ALL cells, which was followed by apoptosis, as shown by annexin V binding and DNA fragmentation. Thus, clotrimazole is cytotoxic to ALL cells at concentrations achievable in vivo.


Subject(s)
Antifungal Agents/pharmacology , Apoptosis/drug effects , Calcium/metabolism , Clotrimazole/pharmacology , Precursor Cell Lymphoblastic Leukemia-Lymphoma/drug therapy , Adolescent , Annexin A5/metabolism , Child , Child, Preschool , DNA Fragmentation/drug effects , Humans , Infant , Lymphocytes/drug effects , Lymphocytes/metabolism , Lymphocytes/pathology , Precursor Cell Lymphoblastic Leukemia-Lymphoma/metabolism , Precursor Cell Lymphoblastic Leukemia-Lymphoma/pathology , Tumor Cells, Cultured
20.
Diabetes Care ; 23(8): 1092-6, 2000 Aug.
Article in English | MEDLINE | ID: mdl-10937503

ABSTRACT

OBJECTIVE: To estimate the prevalence of diabetes in participants of an annual health checkup in the district of the Miyako Public Health Center (Okinawa, Japan) by using the revised criteria of the Japan Diabetes Society (JDS). RESEARCH DESIGN AND METHODS: The subjects studied here were all Japanese and 45-75 years of age at the time of the health examination in 1998. Diagnosis of diabetes was based on the following: 1) fasting plasma glucose > or =7.0 mmol/l, 2) casual plasma glucose > or =11.1 mmol/l, 3) HbA(1c) > or =6.1%, and 4) self-report on a special questionnaire given at the examination. The HbA(1c) value was standardized by the measurement of 2 standard samples provided by the JDS. RESULTS: Among the 2,621 subjects, 59.7% had their fasting blood glucose levels measured. Of the subjects diagnosed as having diabetes, 154 (12.6%) were men and 115 (8.6%) women. Among the subjects newly diagnosed with diabetes from their fasting blood glucose levels. 27.5% of the men and 21.9% of the women had diagnoses based on HbA(1c) alone. Overall, 34.9% of the subjects with newly diagnosed diabetes were identified by plasma glucose (PG) alone and 33.0% were diagnosed by HbA(1c) alone. CONCLUSIONS: The combination of PG and HbA(1c) resulted in a considerable increase in newly diagnosed diabetes as compared with the use of only one of these parameters. Considering the convenience and correlation with vascular complications, use of the 2 tests may be beneficial in epidemiological studies of the Japanese population to identify high-risk groups for micro- and macrovascular diseases.


Subject(s)
Blood Glucose/analysis , Diabetes Mellitus/epidemiology , Glycated Hemoglobin/analysis , Aged , Biomarkers/blood , Body Mass Index , Community Health Centers , Diabetes Mellitus/diagnosis , Diabetes Mellitus/genetics , Family , Fasting , Female , Humans , Hypertension/epidemiology , Japan/epidemiology , Male , Middle Aged , Prevalence , Surveys and Questionnaires
SELECTION OF CITATIONS
SEARCH DETAIL